Literature DB >> 17573788

Impact of diabetes on recurrence of hepatocellular carcinoma after surgical treatment in patients with viral hepatitis.

Takuya Komura1, Eishiro Mizukoshi, Yuki Kita, Masaru Sakurai, Yoshiko Takata, Kuniaki Arai, Tatsuya Yamashita, Tetsuo Ohta, Koichi Shimizu, Yasunari Nakamoto, Masao Honda, Toshinari Takamura, Shuichi Kaneko.   

Abstract

OBJECTIVES: Consensus has been reached that diabetes is a risk factor for development of HCC, but the impact on postoperative recurrence is still controversial. To clarify this point, we analyzed the relationship of postoperative recurrence rate of HCC and coexistence of diabetes in the patients with viral hepatitis.
METHODS: A total of 90 patients who had undergone curative resection for HCC were analyzed. They were divided into two groups with and without diabetes, and the recurrence-free survival rates after surgical treatment and the factors contributing to recurrence were examined.
RESULTS: Kaplan-Meier survival analysis showed the recurrence-free survival rates in the diabetic group were significantly lower than those in the nondiabetic group (P= 0.005) and overall survival rates in the diabetic group were significantly lower than those in the nondiabetic group (P= 0.005). These results were emphasized in the analysis of patients infected with hepatitis C virus. Univariate and multivariate analyses showed diabetes was a significant factor contributing to HCC recurrence after treatment. Furthermore, multivariate analysis in HCC patients with diabetes showed Child-Pugh classification B (P= 0.001) and insulin therapy (P= 0.049) were significant factors contributing to HCC recurrence after treatment.
CONCLUSIONS: The results of the present study suggest that diabetes is a risk factor for the recurrence of HCV-related HCC and decreases the overall survival rates after surgical treatment. HCV-related HCC patients with diabetes should be closely followed for postoperative recurrence.

Entities:  

Mesh:

Year:  2007        PMID: 17573788     DOI: 10.1111/j.1572-0241.2007.01354.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  25 in total

1.  Insulin resistance and chronic liver disease.

Authors:  Takumi Kawaguchi; Eitaro Taniguchi; Minoru Itou; Masahiro Sakata; Shuji Sumie; Michio Sata
Journal:  World J Hepatol       Date:  2011-05-27

2.  Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma.

Authors:  Wen-Yi Shau; Yu-Yun Shao; Yi-Chun Yeh; Zhong-Zhe Lin; Raymond Kuo; Chih-Hung Hsu; Chiun Hsu; Ann-Lii Cheng; Mei-Shu Lai
Journal:  Oncologist       Date:  2012-05-23

3.  Diabetes mellitus impairs the response to intra-arterial chemotherapy in hepatocellular carcinoma.

Authors:  Yin-Hsun Feng; Cheng-Yao Lin; Wen-Tsung Huang; Chia-Ling Wu; Jui-Lung Fang; Chao-Jung Tsao
Journal:  Med Oncol       Date:  2010-08-24       Impact factor: 3.064

4.  Effect of Intramuscular Adipose Tissue Content on Prognosis in Patients Undergoing Hepatocellular Carcinoma Resection.

Authors:  Masaki Kaibori; Morihiko Ishizaki; Hiroya Iida; Kosuke Matsui; Tatsuma Sakaguchi; Kentaro Inoue; Toshihiko Mizuta; Yasushi Ide; Junji Iwasaka; Yutaka Kimura; Fumikazu Hayashi; Daiki Habu; Masanori Kon
Journal:  J Gastrointest Surg       Date:  2015-05-12       Impact factor: 3.452

Review 5.  Importance of hepatitis C virus-associated insulin resistance: therapeutic strategies for insulin sensitization.

Authors:  Takumi Kawaguchi; Michio Sata
Journal:  World J Gastroenterol       Date:  2010-04-28       Impact factor: 5.742

Review 6.  Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link.

Authors:  Abby B Siegel; Andrew X Zhu
Journal:  Cancer       Date:  2009-12-15       Impact factor: 6.860

Review 7.  Diabetes mellitus and metformin in hepatocellular carcinoma.

Authors:  Koji Fujita; Hisakazu Iwama; Hisaaki Miyoshi; Joji Tani; Kyoko Oura; Tomoko Tadokoro; Teppei Sakamoto; Takako Nomura; Asahiro Morishita; Hirohito Yoneyama; Tsutomu Masaki
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

8.  Hyperglycemia is a significant prognostic factor of hepatocellular carcinoma after curative therapy.

Authors:  Takanori Hosokawa; Masayuki Kurosaki; Kaoru Tsuchiya; Shuya Matsuda; Masaru Muraoka; Yuichiro Suzuki; Nobuharu Tamaki; Yutaka Yasui; Toru Nakata; Takashi Nishimura; Shoko Suzuki; Ken Ueda; Hiroyuki Nakanishi; Jun Itakura; Yuka Takahashi; Namiki Izumi
Journal:  World J Gastroenterol       Date:  2013-01-14       Impact factor: 5.742

Review 9.  Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis.

Authors:  Bethany B Barone; Hsin-Chieh Yeh; Claire F Snyder; Kimberly S Peairs; Kelly B Stein; Rachel L Derr; Antonio C Wolff; Frederick L Brancati
Journal:  JAMA       Date:  2008-12-17       Impact factor: 56.272

10.  Decreased expression of insulin and increased expression of pancreatic transcription factor PDX-1 in islets in patients with liver cirrhosis: a comparative investigation using human autopsy specimens.

Authors:  Masahiro Sakata; Akihiko Kawahara; Takumi Kawaguchi; Jun Akiba; Tomoki Taira; Eitaro Taniguchi; Mitsuhiko Abe; Hironori Koga; Masayoshi Kage; Michio Sata
Journal:  J Gastroenterol       Date:  2012-07-12       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.